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Abstract
Objective—The circadian hormone melatonin has wide-reaching effects on human physiology. 
In adolescents, the impact of nighttime light exposure and other modifiable behavioral factors on 
melatonin levels is poorly understood.
Design—We cross-sectionally examined the influence of nighttime behaviors on melatonin levels 
in 100 adolescents (average age: 15.7; 55 female, 45 male), who completed a self-administered 
questionnaire and provided a first morning urine sample to assay for urinary 6-sulfatoxymelatonin 
(aMT6s) levels. We used mixed-effects regression models to test for differences in aMT6s levels 
by categories of covariates.
Results—Self-reported sleep duration, ambient light levels during sleep, and use of electronics 
after turning off lights did not significantly predict aMT6s levels. Compared to those who reported 
weekend bedtimes before 11pm, urinary aMT6s levels were significantly lower among participants 
reporting weekend bedtimes after midnight (52.5 vs. 38.0 ng/mg creatinine, Ptrend=0.007). Sleep 
interruption also appeared to be significantly associated with lower urinary aMT6s levels, but only 
if lights were turned on during sleep interruption (43.0 ng/mg creatinine for participants with sleep 
interruption but not turning lights on, vs. 24.6 ng/mg creatinine for participants reporting that they 
turned on the light when their sleep was interrupted Pdifference=0.032).
Conclusions—Our study suggests that self-reported sleep-related behaviors have little to no 
effect on adolescent circadian systems, though larger studies are needed to confirm our findings.
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INTRODUCTION
National-level data indicate that sleep problems are endemic among US teenagers1. The 
circadian system undergoes rapid changes in puberty that may predispose adolescents to fall 
asleep and wake up at later times than adults2,3. Often, this developing physiology conflicts 
with early school start times: in a national survey, nearly half of adolescent respondents 
reported that they slept less than the recommended 8 hours on weeknights1. Sleep 
deprivation is associated with a number of adverse outcomes in youths, including 
impairments in mood and behavior4, poor academic performance5, and possibly obesity6. In 
adults, disruption of the circadian sleep cycle has been associated with an increased risk of 
cancer7.
While some evidence suggests that delaying school start times even a small amount may 
decrease fatigue and improve mood8, implementing changes to school schedules is not 
generally a feasible option for most school districts. As a result, more research is needed to 
quantify the impact of modifiable factors – such as nighttime light exposure – on adolescent 
health.
The effects of sleep on health may be mediated through the circadian hormone melatonin, 
which has wide-reaching effects on human physiology and is an emerging biomarker for 
adult chronic diseases. Melatonin secretion in humans exhibits diurnal variation: levels are 
lowest during the day, and peak overnight during sleep9. Melatonin release from the pineal 
gland may also be suppressed by exogenous factors, particularly natural and artificial light10. 
In studies of adults, significant inverse associations between exposure to light at night – 
often resulting from nightshift work – and melatonin levels have been documented11. 
However, the relationships between similar exposures and melatonin levels in younger 
populations have not been widely studied.
In the present analysis, we cross-sectionally examined associations between nighttime 
behaviors and urinary markers of melatonin levels in adolescents. All participants provided 
self-reported information about sleep-related factors, as well as a first-morning urine sample 
was assayed to quantify melatonin levels on a mid-week night during the school year.
SUBJECTS & METHODS
Study population and Procedures
Between the months of April and May 2011, students in grades 9–12 at a suburban New 
York high school were recruited for participation via flyers and in-classroom presentations 
by one of the investigators (C.H). All students willing to answer a short questionnaire and 
provide a first-morning urine sample on designated study date were eligible for inclusion. 
Written consent was obtained from all participants, and from the parent or guardian of each 
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participant. All procedures were conducted with approval of the Ossining High School 
Institutional Review Board.
Instrumentation
Participants were given two days in late May 2011 to complete a paper questionnaire aimed 
at assessing nighttime habits, light exposure and sleep duration. In addition to assessing 
demographic and lifestyle characteristics, questionnaire items queried: 1) Time at which 
participants turned off the light to go to sleep and time at which they woke up on each day of 
a usual week; 2) Number of hours usually spent looking at an electronic device (e.g. a laptop 
or desktop computer, a television) after lights are turned off to go to sleep; 3) Use of sleep 
aids, and type; 4) Whether a light or television was turned on in, or near, the bedroom while 
sleeping; 5) Average number of times per night, if any, that their sleep was interrupted; 6) If 
sleep was interrupted, participants were asked to indicate whether they turned a light on, and 
intensity (bright or dim) and duration (<5, 5–10, or ≥10 minutes) of light exposure; 7) 
Average sleep duration (in hours) for weekdays and weekend night, separately; 8) Level of 
ambient light present in the bedroom during sleep on weekdays, weekends, and night prior 
to urine collection.
Ambient light levels were classified according to the numerical scale established by Davis et 
al.12: 1) Subject wears a mask to keep out the light; 2) Subject cannot see his/her hand in 
front of his/her face; 3) Subject can see to the end of the bed; 4) Subject can see across the 
room; 5) Subject can barely read; and 6) Subject can read comfortably.
Time spent in bed in on weekends and weekdays was calculated as the difference between 
the hour at which participants reported getting into bed with the lights off and the hour at 
which they reported waking. Participants were also asked to provide the location of their 
current residence, duration of residence at that address, and whether artificial outdoor light 
was visible from their bedroom window.
Between June and July 2012, additional information about participants’ chronotype was 
collected via email. Respondents answered a single question from the Horne-Osterberg 
Morningness-Eveningness Questionnaire13, indicating whether they most closely identified 
as: 1) A definite “morning” type; 2) Rather more of a “morning” type than an “evening” 
type; 3) Rather more of an “evening” type than a “morning” type; or 4) A definite “evening” 
type. This item has previously been shown to correspond well to the overall questionnaire 
score14.
Urine Collection
On May 25, 2011, all participants collected first-morning urine samples in their homes using 
4.5mL tubes provided by the investigators. All samples were collected when participants 
arrived at school, between approximately 7:30 and 8:00 am, and were immediately placed 
on ice and transported within 6 hours to the Specialty Assay Research Core Lab (Boston, 
MA). Eleven random urine samples were split as blinded quality control and quality 
assurance for the laboratory analysis.
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Laboratory methods
Urinary melatonin (6-sulfatoxymelatonin, aMT6s) measurements were assayed using 
commercially available ELISA kits (ALPCO, Windham, NH). The Bühlmann 6-SMT 
ELISA is an immunoassay using an antibody-capture technique with a lower detection limit 
of 0.8 ng/ml for aMT6s. All aMT6s assays are creatinine-standardized to account for 
differences arising from variations in urine concentrations. Urine creatinine was measured 
using the COBAS Integra 400 (Roche Diagnostics, Indianapolis, IN. To assess 
reproducibility of the laboratory methods, masked split specimens included within each 
batch (10% of the total samples) were used to calculate the coefficient of variation within 
batches; for urinary aMT6s the average within-batch CV among the samples was 3.3% and 
for creatinine, 1.4%.
Statistical methods
No study participants were missing aMT6s levels, and none of the aMT6s values were 
identified as outliers based on the generalized extreme studentized deviate many-outlier 
detection approach,15 leaving a total of 100 students available for our analyses.
All statistical analyses were performed with SAS software (SAS Institute, Cary, NC). 
Fisher’s exact tests were used to examine univariate relationships between chronotype and 
reported sleep habits. Continuous variables in Table 1 are presented as means (standard 
deviation, SD). To test for differences in aMT6s levels by categories of covariates, we used 
mixed-effects regression models to obtain geometric mean aMT6s levels and 95% 
confidence intervals (95% CI). Main models were adjusted for age (years, continuous), sex, 
body mass index (k/m2, continuous), alcohol consumption (any v. none), physical exercise 
(<4 hours per week v. 4+ hours per week), and ethnicity (white/Caucasian v. other). Further 
adjustment for sleep duration did not materially change results, and this covariate was not 
retained in final models. When the underlying variable was continuous, such as age or BMI, 
P-values are reported for the linear trend test. For categorical variables, we estimated P for 
trend by modeling categories ordinally, or by modeling the medians of the categories 
continuously. In secondary analyses, we also calculated P for differences between extreme 
categories. We present them only for light exposure during sleep interruption (levels among 
those whose sleep was never interrupted v. levels among those who reported turning a light 
on when their sleep was interrupted), as this was the only variable where we observed 
significant differences. All P-values were based on two-sided tests and were considered 
statistically significant if ≤ 0.05. Complete case approach was used for all analyses.
In sensitivity analyses, we excluded smokers, those who reported using sleep aids and 
female participants reporting the use of oral contraceptives. Because their exclusion did not 
alter our findings, we retained these individuals in our main analyses. In secondary analyses 
exploring the association between light outside the bedroom window and urinary melatonin 
levels, we excluded the two students who reported having lived at their current residence for 
8 months or fewer.
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RESULTS
Study population
Characteristics of the study participants are shown in Table 1. 55 participants (55%) were 
female and 44 (44%) were male. One participant did not report sex; this individual was 
retained in all analyses not stratified by sex. Ages of participants ranged from 14 to 18 years, 
with a mean age of 15.7 (SD=1.2). BMI ranged from 15.4 to 37.1 kg/m2, with a mean of 
21.6 (SD=3.5). Students predominantly identified as Caucasian (67.8%).
Sleep habits
Both self-reported sleep duration and calculated time spent in bed with the lights off were 
longer on the weekends than the weekdays. On weekdays, average self-reported sleep 
duration was 6.9 hours (SD=1.03), while average time spent in bed was 7.7 hours 
(SD=0.86). The Spearman correlation between these two measures was 0.45 (P<0.001). 
During the weekend, average self-reported sleep duration was 8.6 hours (SD=1.42), and 
average time spent in bed was 9.2 hours (SD=1.4). These two measures were also 
significantly correlated, with a Spearman correlation coefficient of 0.43 (P <0.001).
The finding that time spent in bed was longer than the self-reported sleep duration indicated 
that participants had at least some amount of time between turning off the lights and falling 
asleep. On weekdays, 21% of participants reported using electronics for more than one hour 
after turning the lights out and before going to sleep, compared to 49% on the weekends. 
Other sources of ambient light at night reported by participants included light outside their 
bedroom window at night (45%), and 22.2% of participants reported that there was a TV or 
light on inside or near their bedroom while they slept. Asked to rate the brightness level in 
their rooms during the weekday and weekend nights, the largest proportion of students 
reported that they “could see to the end of the bed” (38.0% and 38.4%, respectively).
25 participants (25.3%) reported having their sleep interrupted up to 4 times a night. Among 
this subset, 4 participants – all females – reported turning on a light when their sleep got 
interrupted. Of those who reporting turning on a light when sleep was interrupted, 1 reported 
that the light was dim, while 3 reported turning on a bright light.
Most students in our sample identified as evening types, with 56 (70.8%) identifying as 
either “strong evening” or “more evening than morning” types. Chronotype was not 
significantly associated with self-reported sleep duration, time spent in bed, or wakeup times 
on weekdays or weekends. However, evening chronotypes reported significantly later 
bedtimes during the weekend than participants who identified as morning types (P=0.025).
Sleep habits and aMT6s levels
Table 2 shows age- and multivariate-adjusted geometric mean first morning urinary aMT6s 
(ng/mg creatinine) levels by participant characteristics. Age was not significantly associated 
with aMT6s levels in univariate or multivariate analyses (Ptrend=0.743, and 0.809, 
respectively). Similarly, sex, BMI, race, alcohol use, physical activity and use of sleep aids 
showed no significant associations with aMT6s levels, though participants who reported 
Hersh et al. Page 5
Hormones (Athens). Author manuscript; available in PMC 2018 March 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
alcohol use had non-significantly lower melatonin than those who did not (33.2 ng/mg 
creatinine v. 44.9 ng/mg creatinine, P=0.072). In age-adjusted analyses, older age at 
menarche was associated with higher aMT6s levels (Ptrend=0.002); multivariate adjustment 
did not alter this association (Ptrend=0.001). Similarly time since menarche was also 
inversely associated with aMT6s levels in both univariate (Ptrend=0.017) and multivariate 
analyses (Ptrend=0.024). Though based on small numbers of users, oral contraceptive use 
appeared to be associated with higher aMT6s (43.6 ng/mg creatinine v. 65.6 ng/mg 
creatinine, P=0.032).
In multivariate analyses, few self-reported behaviors or light exposures at night significantly 
predicted circulating aMT6s levels (Table 3). Self-reported exposure to ambient light at 
night in the bedroom did not appear to significantly affect nightly melatonin levels. AMT6s 
levels did not meaningfully vary by self-reported exposure to light at night outside the 
bedroom window, electronic use after lights out, whether or not light or a TV was on during 
sleep, or brightness levels in the bedroom at night on weekdays, weekends, or the night 
before the collection.
No significant trend between aMT6s levels and reported bedtime on the weeknights was 
observed (Ptrend=0.317), though later reported bedtimes on the weekend were significantly 
inversely associated with aMT6s levels (38.0 ng/mg creatinine for bedtimes after midnight v. 
52.5 ng/mg creatinine for bedtimes before 11pm, Ptrend=0.007). Lastly, neither self-reported 
sleep duration nor time spent in bed on either weekdays or weekends appeared to be a 
significant predictor of aMT6 levels.
We also explored associations between aMT6s levels and self-reported light exposure during 
sleep interruption. Borderline significantly lower aMT6s levels were found among the four 
participants who turned the light on if their sleep got interrupted at night (24.6 ng/mg 
creatinine, 95% CI: 14.9, 40.5) when compared to adolescents with interrupted sleep who 
did not turn the light on (43.1 ng/mg creatinine, 95% CI: 33.5, 55.6, Pdifference=0.050) and 
significantly lower levels were observed when compared to those who had their sleep never 
interrupted (43.0 ng/mg creatinine, 95% CI: 37.8, 48.9, Pdifference=0.032). No significant 
differences were observed comparing participants with interrupted sleep who did not turn 
the light on compared to those whose sleep was not interrupted (Pdifference=0.981).
Self-reported chronotype was not associated with aMT6s levels (Ptrend=0.157), though there 
was some association of a non-linear relationship. aMT6s levels were highest among those 
who self-identified as “definite” morning or evening types, and lower among those who 
reported being “more” of a morning or evening type.
DISCUSSION
This study is among the first to examine relationships between adolescent sleep patterns and 
behaviors and urinary measures of melatonin. In our sample of high school students, we 
found that few aspects of adolescent sleep behavior and self-reported nocturnal light 
exposure were associated with urinary aMT6s levels.
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Though exposure to light at night is known to suppress melatonin secretion, no associations 
between any self-reported measure of ambient light in or around the bedroom and aMT6s 
levels were observed in the present study. While laboratory studies have demonstrated the 
ability of light at night to suppress melatonin levels, the intensity of residential light may be 
orders of magnitude less intense than light used in experimental studies, and insufficient to 
quantifiably affect melatonin secretion16. The effect of ambient light on melatonin is likely 
further reduced during sleep, when eyelids are closed, as mean light transmittance across the 
human eyelid has been reported to be as low as 1%17. While high-intensity light exposure 
delivered across the eyelids by an over-eye mask has been shown to suppress serum 
melatonin levels and delay dim light melatonin onset (DLMO) in young adults18, these 
experimental conditions are not representative of the light exposures experienced by our 
study participants.
Use of electronic devices after turning off the lights was not found to be a significant 
predictor of aMT6s levels. Melatonin is suppressed by specific wavelengths of blue light, 
especially in the 46–477 nm range19; many electronic devices also emit light in this range of 
the spectrum. Evidence in young adults suggests that devices with light emitting diode 
(LED) displays are stronger suppressors of melatonin than those that emit white light20,21, 
and that significant suppression may occur only after long durations of use22. In one small 
experimental study, nighttime exposure to light from a computer monitor was not associated 
with significantly decreased levels of salivary melatonin in college students23. Our results 
are significant given the prevalence of nighttime electronic use among adolescents; in a 
recent national survey, the proportions of 13–18 year old respondents who reported regularly 
using a cellphone or a computer in the hour before trying to go to sleep were 72% and 60%, 
respectively24.
Interestingly, participants in our study who reported the latest weekend bedtimes were found 
to have the lowest midweek melatonin levels. Compared to adults, adolescents are likely to 
have a delayed circadian phase, even in the absence of social pressures2,25,26, and these 
phase delays may manifest as a later DLMO2,27. We hypothesize that falling asleep later on 
the weekends may be an indicator of delayed circadian phase. Because all students in our 
students in our study began school at the same time (7:45am) on the day of urine collection, 
it is reasonable to assume that participants had a similar wake-up time. Among students with 
a delayed circadian phase, the time from DLMO to this fixed wake-up time was shorter, and 
as such, their first morning urine sample reflected an incomplete overnight secretion of 
melatonin. Therefore, low melatonin levels may be identifying a group of students whose 
circadian tendencies are most in conflict with school start times. However, the lack of an 
association between weekend bedtimes and self-reported chronotype makes this finding 
difficult to interpret.
Our suggestive finding that exposure to light during sleep interruption is associated with 
lower aMT6s levels is given some support by evidence demonstrating that exposure to light 
at night suppresses the secretion of melatonin by the pineal gland9,28,29. However, 
experimental study protocols, generally involve continuous exposure to light for several 
hours during normal sleep hours at relatively high intensities of light9,10. In contrast, only 
one participant in our study reported leaving lights on for 10 or more minutes during sleep 
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interruption. Given that light interruption in our study was brief, and that the primary reason 
for sleep interruption may have been to urinate, which could have lowered first-morning 
urinary melatonin measures, these results must be interpreted with caution. Further, the 
small number of participants who reported exposure to light during sleep interruption must 
be considered.
Though aMT6s levels and BMI have been found to be correlated in adults11, we could not 
confirm this association in our adolescent population, consistent with a recent study in 
adolescent Korean girls30. Additionally, we observed a non-significant decrease in aMT6s 
levels among participants who reported alcohol use: alcohol consumption has been 
correlated with decreased melatonin levels in some31,32, though not all11,33, studies of 
adults. In multivariate analyses, higher melatonin levels were observed among girls who 
reported a later age at menarche. While age at menarche was not associated with aMT6s 
levels in adult women11 Crowley et al.34 recently reported that advancing Tanner stage was 
associated with decreases in overnight melatonin secretion among adolescents. Since 
menarche can be used as a pubertal marker35, our results appear consistent with these prior 
findings, as girls in our study who experienced menarche earlier may have been more 
pubertally advanced than girls with more recent menarche. Our finding that time since 
menarche was inversely associated with aMT6s levels also supports this hypothesis. Lastly, 
in multivariate analyses, we found that girls had non-significantly higher aMT6s levels 
compared to boys. Higher melatonin secretion in adolescent girls was reported by Crowley 
et al.34, though other studies of melatonin in adolescents did not find significant sex 
differences36–38.
This study has several strengths. First, our sample size is larger than most other studies of 
melatonin in adolescents, and is the first to observe lifestyle correlates of urinary aMT6s 
levels in an adolescent population. Previous work has shown that single measurements of 
aMT6s in first-morning urine are highly correlated to peak and total plasma melatonin 
levels37, and that aMT6s levels from samples collected in the field and the laboratory were 
in close agreement39. Therefore, our measurements of aMT6s in first-morning urine provide 
an adequate representation of nocturnal melatonin levels, as well as a non-intrusive method 
of sample collection that is acceptable to adolescent participants.
The main limitation of our study is its cross-sectional nature. In adults, levels of urinary 
aMT6s have been shown to have high reproducibility over long periods40, though it remains 
unclear whether a single measurement of melatonin in adolescents is an adequate 
representation of long-term levels. Some evidence suggests that melatonin levels decline 
throughout childhood and puberty34,41,42, though other evidence suggests that urinary 
aMT6s secretion may remain constant after the onset of puberty36. Griefahn et al.37 reported 
that despite huge between-subject variability, within-subject levels of urinary excretion of 
melatonin metabolite remained constant from ages 3 to 18. An additional limitation of our 
study was that it relied on self-reported light levels, and not objective, standardized measures 
of ambient light. However, these light levels are more indicative of the levels that 
adolescents are habitually exposed to, in contrast to the light stimuli used in many 
experimental protocols.
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This is the first study to date to present correlations between sleep patterns and behaviors 
and urinary melatonin levels in an adolescent population. Our results suggest that the 
nighttime behaviors of adolescents by and large do not impact urinary melatonin levels. 
Given the prevalence of sleep deprivation among adolescents, and the gravity of its 
consequences, more research is needed to elucidate the pathways through which such sleep-
related factors may impact physiology.
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Table 1
Characteristics of 100 study participants, overall and by gender*
Characteristic Overall Females Males
N (%) 100 (100.0) 55 (55.6) 44 (44.4)
Age, years 15.7 (1.2) 15.8 (1.3) 15.5 (1.0)
BMI, kg/m2 21.6 (3.5) 22.0 (4.0) 21.1 (2.8)
Melatonin level, ng/mL 72.3 71.4 71.2
Creatinine level, mg/dL 158.6 152.5 165.0
Age at first menstrual period, median (range)† N/A 12 (9–14) N/A
Caucasian (%) 67 (67.8) 33 (61.1) 33 (75.0)
Reported tobacco use 2 (2.0) 0 (0.0) 2 (4.8)
Reported alcohol use in past 30 days 18 (18.6) 11 (20.0) 7 (17.9)
Current OC Use† N/A 5 (9.3) N/A
Exercise 4 or more hours/week 67 (67.1) 35 (64.8) 32 (76.2)
Use of sleep aid in past 3 months 8 (8.0) 6 (10.9) 2 (4.6)
*One individual did not provide data on gender but was retained in all analyses not stratified by sex
†
Females only
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Table 2
Age- and multivariate* adjusted geometric mean aMT6s levels (ng/mg) by selected characteristics
Age-adjusted Fully adjusted
Characteristic Category
Definition
N† Geometric mean
aMT6s, 95%
confidence
interval
Geometric mean
aMT6s, 95%
confidence
interval
Age, years** 14 20 43.3 (31.8, 60.0) 42.7 (30.3, 60.3)
15 27 40.0 (30.8–50.9) 44.9 (36.5, 55.2)
16 28 35.5 (30.0, 43.5) 34.3 (27.7, 43.4)
17 17 46.0 (38.2, 55.3) 50.0 (41.3, 60.6)
18 8 47.6 (31.2, 71.5) 46.4 (31.4, 68.4)
P for trend‡ 0.743 0.809
Gender Male 44 37.2 (30.2, 45.9) 39.3 (32.4, 47.8)
Female 55 43.8 (38.7, 49.7) 44.7 (39.1, 51.1)
P for difference 0.182 0.283
BMI, kg/m2 <20 39 43.9 (36.3, 53.0) 43.3 (35.4, 53.0)
20–25 48 38.1 (32.1, 45.1) 40.5 (35.2, 46.5)
>25 13 43.7 (32.7, 58.5) 42.7 (31.2, 58.4)
P for trend‡ 0.487 0.563
Ethnicity Caucasian 67 43.0 (37.0, 50.0) 42.9 (37.1, 49.7)
Non-Caucasian 32 36.9 (30.7, 44.4) 40.8 (34.6, 48.1)
P for difference 0.214 0.648
Age at menarche, years§ 9 1 39.8 (36.8, 43.1) -
10 4 20.4 (12.7, 33.0) 18.3 (12.2, 29.1)
11 7 32.5 (24.1, 43.6) 33.5 (25.0, 44.9)
12 16 51.3 (42.7, 61.6) 51.9 (43.7, 61.4)
13 18 50.7 (42.0, 61.2) 50.3 (41.6, 60.8)
14 7 50.9 (38.7, 66.9) 52.9 (38.0, 73.6)
P for trend‡ 0.002 0.001
Time since menarche, years**,§ 1 5 61.2 (36.9, 101.4) 58.9 (34.6, 100.3)
2 12 55.5 (42.0, 73.3) 58.1 (40.5, 83.4)
3 11 49.6 (39.7, 61.9) 50.7 (41.5, 61.9)
4 10 38.3 (30.4, 48.2) 39.8 (32.7, 48.4)
≥5 15 34.6 (26.2, 45.7) 32.5 (23.2, 45.5)
P for trend‡ 0.017 0.024
Oral contraceptive use§ Yes 5 65.0 (46.7, 90.5) 65.6 (46.7, 92.3)
No 50 43.1 (38.0, 49.0) 43.6 (38.2, 49.7)
P for difference 0.025 0.032
Tobacco use Yes 2 27.6 (19.3, 39.5) 51.7 (37.4, 71.5)
No 96 42.4 (37.87, 47.5) 42.2 (37.5, 47.4)
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Age-adjusted Fully adjusted
Characteristic Category
Definition
N† Geometric mean
aMT6s, 95%
confidence
interval
Geometric mean
aMT6s, 95%
confidence
interval
P for difference 0.026 0.266
Alcohol use, past 30 days Yes 18 33.4 (23.9, 46.7) 33.2 (24.0, 50.3)
No 70 44.7 (40.2, 49.8) 44.9 (40.1, 50.3)
P for difference 0.096 0.072
Physical activity, hours/week <4 30 43.7 (35.2, 54.2) 44.4 (35.1, 56.1)
≥4 67 40.5 (35.6, 46.1) 41.5 (36.5, 47.1)
P for difference 0.545 0.614
Use of sleep aids Yes 8 48.2 (33.3, 69.9) 50.4 (36.1, 70.4)
No 92 40.4 (35.7, 45.6) 41.7 (36.9, 47.1)
P for difference 0.366 0.290
*Adjusted for: age, gender, ethnicity, BMI, smoking status (yes/no), alcohol consumption (yes/no), physical activity for 4 h/wk or more (yes/no)
†Actual numbers of participants in analyses may vary due to missing covariates;
**Not age-adjusted;
‡
Ptrend calculated by modeling variables continuously;
§
Females only
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Table 3
Multivariate-adjusted* geometric mean aMT6s (ng/mg creatinine), by category of light at night and sleep 
duration among 100 study participants
Characteristic Category Definition N† Geometric mean
aMT6s, 95%
confidence interval
Light outside bedroom window Yes 45 45.8 (39.1, 53.7)
No 54 39.6 (33.4, 46.9)
P for difference 0.228
Electronic use after lights out, weekdays <1 hour 79 43.9 (38.69, 49.7)
1–2 hours 18 34.7 (27.3, 44.1)
≥ 3 hours 3 55.3 (43.1, 70.8)
P for trend‡ 0.611
Electronic use after lights out, weekends <1 hour 51 45.6 (39.2, 53.0)
1–2 hours 41 39.7 (32.8, 48.1)
≥3 hours 8 36.8 (27.0, 50.1)
P for trend‡ 0.163
Sleep interrupted Never interrupted 73 43.0 (37.8, 48.9)
1–4 times/night without light on 21 43.1 (33.5, 55.6)
1–4 times/night with light on 4 24.6 (14.9,40.5)
P for difference (never vs. 1–4 times/night 
with light on) 0.032
*
Light or TV on in or near bedroom overnight Yes 22 43.7 (37.4, 51.1)
No 78 41.9 (36.5, 48.1)
P for difference 0.647
Average self-reported sleep duration, weekdays <5 hours 3 73.4 (60.3, 89.3)
5–6 hours 28 35.5 (27.6, 45.5)
7–8 hours 66 44.1 (38.4, 50.7)
≥ 9 hours 2 30.8 (16.0, 59.5)
P for trend‡ 0.691
Average self-reported sleep duration, weekends <5 hours 3 40.9 (25.2, 66.6)
5–6 hours 7 23.4 (12.7, 43.1)
7–8 hours 28 44.3 (36.4, 53.9)
9–10 hours 49 45.2 (39.1, 52.2)
>10 hours 12 41.7 (31.5, 55.2)
P for trend‡ 0.121
Self-reported brightness level in bedroom, weekdays Level 1 (wearing a mask) 0 -
Level 2 (cannot see hands) 32 39.7 (31.5, 50.1)
Level 3 (can see to end of bed) 24 40.8 (33.4, 49.8)
Level 4 (can see across room) 38 44.5 (36.8, 53.7)
Level 5 (can barely read) 3 103.9 (68.8, 156.8)
Level 6 (can read comfortably) 3 31.3 (19.8, 49.7)
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Characteristic Category Definition N† Geometric mean
aMT6s, 95%
confidence interval
P for trend‡ 0.403
Self-reported brightness level in bedroom, night before collection Level 1 (wearing a mask) 0 -
Level 2 (cannot see hands) 30 39.0 (30.5, 49.9)
Level 3 (can see to end of bed) 21 40.0 (32.0, 50.1)
Level 4 (can see across room) 33 46.8 (39.3, 55.8)
Level 5 (can barely read) 3 73.5 (41.4, 130.5)
Level 6 (can read comfortably) 2 32.4 (26.1, 40.2)
P for trend‡ 0.096
Average reported bedtime, weekdays Before 11pm 56 44.6 (38.0, 52.3)
11pm to midnight 38 38.4 (31.8, 46.2)
After midnight 4 41.8 (25.8, 67.7)
P for trend‡ 0.317
Average reported bedtime, weekends Before 11pm 12 52.5 (42.4, 64.9)
11pm to midnight 24 48.8 (40.8, 58.4)
After midnight 61 38.0 (32.4, 44.5)
P for trend‡ 0.007
Chronotype Definite morning type 5 50.7 (40.5, 63.4)
More morning type than evening 18 32.4 (23.6, 44.4)
More evening type than morning 39 45.2 (38.8, 52.8)
Definite evening type 17 50.2 (38.7, 65.1)
P for trend‡ 0.157
*Adjusted for: age, gender, ethnicity, BMI, alcohol consumption (yes/no), physical activity for 4 h/wk or more (yes/no)
†Actual numbers of participants in analyses may vary due to missing covariates
‡Ptrend calculated by modeling median of each category as continuous, or by modeling ordinal categories continuously
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